Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing

In daily routine, IHC could support FISH in the identification of ALK altered NSCLCs. Further research is needed to assess the role of discordant MET results by means of IHC and FISH as well as the relevance of tumors with an increased ROS1 gene copy number.